TS-1 (S-1)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TS-1 (S-1), covering 2012-06-18 to 2023-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) [Phase 2]